Detection of Pattern of Some Unusual Signs and Symptoms of Multiple Sclerosis
Detection of Pattern of Unusual Signs and Symptoms of Multiple Sclerosis
1 other identifier
observational
100
0 countries
N/A
Brief Summary
Each Multiple Sclerosis patient will be submitted to Cognitive Abilities Screening Instrument (CASI), Expanded Disability Status Scale, Epowrth Sleeping Scale(ESS),Fatigue Severity Scale(FSS), Hamilton Depression Rating Scale, Hamilton Anxiety Rating Scale, Headache Disability Index, specific questionnaire based on International Headache Society (IHS) recommendations
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2019
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 17, 2019
CompletedFirst Posted
Study publicly available on registry
September 24, 2019
CompletedStudy Start
First participant enrolled
November 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedOctober 4, 2019
October 1, 2019
2.1 years
September 17, 2019
October 2, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Fatigue severity scale
A self-report scale of nine items about fatigue, its severity and how it affects certain activities. Answers are scored on a seven point scale where 1 = strongly disagree and 7 = strongly agree. This means the minimum score possible is nine and the highest is 63. The higher the score, the more severe the fatigue is and the more it affects the person's activities. It is simple to understand and takes an average of eight minutes to answer
1 year
Eligibility Criteria
The study will include all patients daignosed as multiple sclerosis attending at Assiut university hospital within the prescribed time
You may qualify if:
- Male or female.
- Age:30-50 years
- Accepting all study requirement
You may not qualify if:
- comorbid patient e.g (diabetic, hypertensive.......etc )
- opposition of the patient or their family
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Mahmood M. Yosry Abdelsatar
Study Record Dates
First Submitted
September 17, 2019
First Posted
September 24, 2019
Study Start
November 1, 2019
Primary Completion
December 1, 2021
Study Completion
December 1, 2021
Last Updated
October 4, 2019
Record last verified: 2019-10